biolitec at World Congress of the International Federation of Gynecology and Obstetrics in Rome at booth D17 – HOLA™-lasertherapy for myomas provides gentle and almost painless alternative to conventional methods – Workshop with simulator MyoSim on October 10th
Jena, 05. Oktober 2012 – This coming Sunday, the FIGO World Congress opens its doors. Already for the 20th time, the International Federation of Gynecology and Obstetrics holds its meeting which takes place every three years, this year in the eternal city of Rome. Until October 12th the interested professional audience will have the opportunity to meet up colleagues and to get to know the newest developments in the field of gynaecology. This is just the right context for biolitec AG to present its newest application: the worldwide leading specialist in medical laser technique presents HOLA (Hysteroscopic Outpatient Laser Applications) – the new minimally invasive method for the excision of myomas.
Myomas are often appearing benign tumours of the uterus, by which appr. every fourth or sixth woman of productive age is affected in Europe. Even though myomas in some cases evoke no symptoms, heavy bleedings as well as pain and disturbance in function of organs can appear. Up to now, myomas are usually removed during a surgical or radiologic procedure.
The new HOLA-therapy of biolitec removes myomas of the uterus minimally invasive and with little side effects. A special designed tip of the laser fiber enables contact vaporization of the myoma tissue. The hysteroscopic vaporesection does not have any impact on the lining muscle and enables treatment of even bigger myomas. Interested parties can familiarize with the method during a workshop at the FIGO on October 10th and test virtually the application of HOLATM with the simulator MyoSim. Everybody who cannot attend the workshop is recommended a visit of biolitec“s booth D17 at the FIGO in Rome.
About biolitec:
biolitec® AG is one of the leading companies worldwide in the field of medical laser treatments und the only provider that possesses all relevant core competencies – photosensitizers, laser devices and optical fibres – in the field of photodynamic therapy (PDT). Besides the laser treatment of cancer with Foscan®, biolitec® primarily researches on minimally-invasive and gentle laser treatments and markets them. ELVeS Radial™ (Endo Laser Vein System) the laser system is most often used worldwide for the treatment of varicose veins. Ceralas® HPD laser therapy enables a gentle treatment of e.g. benign prostatic hyperplasia (BPH) in urology. Gentle laser treatments in the fields of proctology, ENT, orthopaedics, gynaecology as well as ophtalmology also belong to the business field of biolitec®. biolitec® is listed in the Prime Standard (ISIN DE0005213409). Further information at www.biolitec.de.
Press Contact:
Jörn Gleisner
Telephone: +49 (0) 6172-27159-20
Telefax: +49 (0) 6172-27159-69
E-Mail: joern.gleisner@biolitec.com
Die biolitec AG ist eines der weltweit führenden Unternehmen im Bereich Laseranwendungen und der einzige Anbieter, der über alle relevanten Kernkompetenzen – Photosensitizer, Laser und Lichtwellenleiter – im Bereich der photodynamischen Therapie (PDT) verfügt. Neben der lasergestützten Behandlung von Krebserkrankungen mit dem Medikament Foscan® erforscht und vermarktet die biolitec AG vor allem minimalinvasive, schonende Laserverfahren. ELVeS Radial™ (Endo Laser Vein System) ist das weltweit am häufigsten eingesetzte Lasersystem zur Behandlung der venösen Insuffizienz. Der Ceralas® HPD Laser ermöglicht eine schonende Behandlung bei z.B. gutartiger Prostatavergrößerung (BPH) in der Urologie. Schonende Laseranwendungen in den Bereichen Proktologie, HNO, Orthopädie, Gynäkologie und Ophthalmologie gehören ebenfalls zum Geschäftsfeld der biolitec AG. biolitec ist im Prime Standard unter der ISIN DE0005213409 notiert. Weitere Informationen unter www.biolitec.de.
Kontakt:
biolitec AG
Jörn Gleisner
Otto-Schott-Straße 15
07745 Jena
+49 (0) 6172/27159-20
info@biolitec.de
http://www.biolitec.de
Pressekontakt:
fr financial relations gmbh
Jörn Gleisner
Louisenstraße 97
61348 Bad Homburg
+49 (0) 6172/ 27159-20
joern.gleisner@biolitec.com
http://www.biolitec.de
